News
Trump sets course for 100%, then 200%, tariffs on generics
Trump has said he intends to impose tariffs of 100% on generic drugs imported into the US from 2028, rising to 200% after a year, in a reshoring push.
News
MSD gets first FDA okay for oral PCSK9 cholesterol drug
MSD has won the race to bring an oral PCSK9 inhibitor through to regulatory approval for LDL cholesterol-lowering in the US.
News
Bayer's Kerendia on course for NHS use in heart failure
Up to 280,000 people with heart failure could soon be eligible for NHS treatment with Bayer's Kerendia, following new NICE guidance.
News
Novo's Wegovy pill cleared for weight loss in EU
The EU has approved Novo Nordisk's pill formulation of weight-loss therapy Wegovy, keeping the company a step ahead of arch rival Eli Lilly.
Market Access
Preparing for the pharma fraud enforcement surge
Here is what robust, risk-based compliance looks like in 2026.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
